CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +120,017 | 288,657 | ||
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −63,610 | $4.88 | $310K | 225,047 |
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Performance Based Restricted Stock Units | −58,204 | 0 | ||
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Performance Based Restricted Stock Units | −120,017 | 0 | ||
| 2026-08-06 | Gendel Mitchell Global General Counsel | Purchase | +2,500 | $4.43 | $11K | 124,883 |
| 2026-08-04 | Merton Carl A Chief Financial Officer | Purchase | +10,000 | $4.62 | $46K | 139,753 |
| 2026-08-03 | FALTISCHEK DENISE M Chief Strategy Officer | Purchase | +2,500 | $4.78 | $12K | 141,285 |
| 2026-07-30 | SIMON IRWIN D President and CEO | Option exercise | +117,647 | 801,666 | ||
| 2026-07-30 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −62,353 | $4.20 | $262K | 739,313 |
| 2026-07-30 | SIMON IRWIN D President and CEO | Option exercise · Restricted Stock Units | −117,647 | 0 | ||
| 2026-07-30 | Merton Carl A Chief Financial Officer | Option exercise | +16,656 | 138,914 | ||
| 2026-07-30 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −9,161 | $4.20 | $38K | 129,753 |
| 2026-07-30 | Merton Carl A Chief Financial Officer | Option exercise · Restricted Stock Units | −16,656 | 0 | ||
| 2026-07-30 | Gendel Mitchell Global General Counsel | Option exercise | +24,379 | 135,304 | ||
| 2026-07-30 | Gendel Mitchell Global General Counsel | Shares withheld for taxes | −12,921 | $4.20 | $54K | 122,383 |
| 2026-07-30 | Gendel Mitchell Global General Counsel | Option exercise · Restricted Stock Units | −24,379 | 0 | ||
| 2026-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +26,120 | 152,629 | ||
| 2026-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −13,844 | $4.20 | $58K | 138,785 |
| 2026-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Restricted Stock Units | −26,120 | 0 | ||
| 2026-07-30 | Looney Thomas P. Director | Grant or award · Restricted Stock Units | +62,657 | 62,657 |
Page 2 of 35 · 686 trades